# Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain

> **NCT00879775** · PHASE2 · COMPLETED · sponsor: **Korea Research Foundation** · enrollment: 41 (actual)

## Conditions studied

- Cancer
- Pain

## Interventions

- **DRUG:** Caffeine
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT00879775
- **Lead sponsor:** Korea Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-07
- **Final completion:** 2009-09
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2011-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00879775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00879775, "Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00879775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*